Clinical benefit of infectious diseases consultation: A monocentric prospective cohort study

Infection

Volumn 40, Issue 5, 2012, Pages 501-507

  De La Blanchardiere A ^a   Boutemy, J ^a   Thibon, P ^a   Michon, J ^a   Verdon, R ^a   Cattoir, V ^a  

^a CAEN UNIVERSITY HOSPITAL   (France)

Author keywords

Adherence to recommendations; Clinical outcomes; IDC; Infectious diseases consultation

Indexed keywords

ANTIINFECTIVE AGENT;

ADULT; AGED; ARTICLE; ATTITUDE TO HEALTH; CHILD; CLINICAL ASSESSMENT; CLINICAL EFFECTIVENESS; COHORT ANALYSIS; CONSULTATION; CONTROLLED STUDY; DIAGNOSTIC TEST; FEMALE; HUMAN; INFECTION; INFECTIOUS DISEASE CONSULTATION; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PATIENT ATTITUDE; PATIENT COMPLIANCE; PHYSICIAN ATTITUDE; PRESCHOOL CHILD; PROSPECTIVE STUDY; TELECONSULTATION;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANALYSIS OF VARIANCE; CHILD; CHILD, PRESCHOOL; COMMUNICABLE DISEASES; FEMALE; HUMANS; INFECTIOUS DISEASE MEDICINE; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PATIENT COMPLIANCE; PROSPECTIVE STUDIES; REFERRAL AND CONSULTATION; TREATMENT OUTCOME;

EID: 84867745339     PISSN: 03008126     EISSN: 14390973     Source Type: Journal    
DOI: 10.1007/s15010-012-0283-0     Document Type: Article

References (34)

1. Sarkar P, Gould IM. Antimicrobial agents are societal drugs: how should this influence prescribing? Drugs. 2006;66:893-901.
2. Scheckler WE, Bennett JV. Antibiotic usage in seven community hospitals. JAMA. 1970;213:264-7.
3. Roberts AW, Visconti JA. The rational and irrational use of systemic antimicrobial drugs. Am J Hosp Pharm. 1972;29: 828-34.
4. Reimann HA. The misuse of antimicrobics. Med Clin North Am. 1961;45:849-56.
5. Marr JJ, Moffet HL, Kunin CM. Guidelines for improving the use of antimicrobial agents in hospitals: a statement by the Infectious Diseases Society of America. J Infect Dis. 1988;157:869-76.
6. Kislak JW, Eickhoff TC, Finland M. Hospital-acquired infections and antibiotic usage in the Boston city hospital - January, 1964. N Eng J Med. 1964;271:834-5.
7. John JF Jr, Fishman NO. Programmatic role of the infectious diseases physician in controlling antimicrobial costs in the hospital. Clin Infect Dis. 1997;24:471-85.
8. Cosgrove SE. The relationship between antimicrobial resistance and patient outcomes: mortality, length of hospital stay, and health care costs. Clin Infect Dis. 2006;42:S82-9.
9. Roberts RR, Hota B, Ahmad I, Scott RD 2nd, Foster SD, Abbasi F, Schabowski S, Kampe LM, Ciavarella GG, Supino M, Naples J, Cordell R, Levy SB, Weinstein RA. Hospital and societal costs of antimicrobial-resistant infections in a Chicago teaching hospital: implications for antibiotic stewardship. Clin Infect Dis. 2009;49:1175-84.
10. Spencer RC. The role of antimicrobial agents in the aetiology of Clostridium difficile-associated disease. J Antimicrob Chemother. 1998;41:21-7.
11. Ghantoji SS, Sail K, Lairson DR, DuPont HL, Garey KW. Economic healthcare costs of Clostridium difficile infection: a systematic review. J Hosp Infect. 2010;74:309-18.
12. McFarland LV. Update on the changing epidemiology of Clostridium difficile-associated disease. Nat Clin Pract Gastroenterol Hepatol. 2008;5:40-8.
13. Dellit TH, Owens RC, McGowan JE Jr, Gerding DN, Weinstein RA, Burke JP, Huskins WC, Paterson DL, Fishman NO, Carpenter CF, Brennan PJ, Billeter M, Hooton TM. Infectious Diseases Society of America and the Society for Healthcare Epidemiology of America guidelines for developing an institutional program to enhance antimicrobial stewardship. Clin Infect Dis. 2007;44:159-77.
14. Davey P, Brown E, Fenelon L, Finch R, Gould I, Hartman G, Holmes A, Ramsay C, Taylor E, Wilcox M, Wiffen P. Interventions to improve antibiotic prescribing practices for hospital inpatients. Cochrane Database Syst Rev. 2005;(4):CD003543.
15. Patel D, Lawson W, Guglielmo BJ. Antimicrobial stewardship programs: interventions and associated outcomes. Expert Rev Anti Infect Ther. 2008;6:209-22.
16. Fowler VG Jr, Sanders LL, Sexton DJ, Kong L, Marr KA, Gopal AK, Gottlieb G, McClelland RS, Corey GR. Outcome of Staphylococcus aureus bacteremia according to compliance with recommendations of infectious diseases specialists: experience with 244 patients. Clin Infect Dis. 1998;27:478-86.
17. Kim BN. Compliance with an infectious disease specialist's advisory consultations on targeted antibiotic usage. J Infect Chemother. 2005;11:84-8.
18. Lo E, Rezai K, Evans AT, Madariaga MG, Phillips M, Brobbey W, Schwartz DN, Wang Y, Weinstein RA, Trenholme GM. Why don't they listen? Adherence to recommendations of infectious disease consultations. Clin Infect Dis. 2004;38:1212-8.
19. Gómez J, Conde Cavero SJ, Hernández Cardona JL, Núñez ML, Ruiz Gómez J, Canteras M, Valdés M. The influence of the opinion of an infectious disease consultant on the appropriateness of antibiotic treatment in a general hospital. J Antimicrob Chemother. 1996;38:309-14.
20. Méan M, Pavèse P, Tudela E, Dinh-Van KA, Mallaret MR, Stahl JP. Consultations with infectious disease specialists for patients in a teaching hospital: adherence in 174 cases. Presse Med. 2006; 35:1461-6.
21. Pulcini C, Pradier C, Samat-Long C, Hyvernat H, Bernardin G, Ichai C, Dellamonica P, Roger PM. Factors associated with adherence to infectious diseases advice in two intensive care units. J Antimicrob Chemother. 2006;57:546-50.
22. Sellier E, Pavese P, Gennai S, Stahl JP, Labarère J, François P. Factors and outcomes associated with physicians' adherence to recommendations of infectious disease consultations for inpatients. J Antimicrob Chemother. 2010;65:156-62.
23. Sellier E, Labarère J, Gennai S, Bal G, François P, Pavese P. Compliance with recommendations and clinical outcomes for formal and informal infectious disease specialist consultations. Eur J Clinical Microbiol Infect Dis. 2011;30:887-94.
24. Gennai S, François P, Bal G, Epaulard O, Stahl JP, Vittoz JP, Pavese P. Evaluation of a remote infectious disease consultation. Med Mal Infect. 2009;39:798-805.
25. Fraser GL, Stogsdill P, Dickens JD Jr, Wennberg DE, Smith RP Jr, Prato BS. Antibiotic optimization. An evaluation of patient safety and economic outcomes. Arch Intern Med. 1997;157: 1689-94.
26. Honda H, Krauss MJ, Jones JC, Olsen MA, Warren DK. The value of infectious diseases consultation in Staphylococcus aureus bacteremia. Am J Med. 2010;123:631-7.
27. Jenkins TC, Price CS, Sabel AL, Mehler PS, Burman WJ. Impact of routine infectious diseases service consultation on the evaluation, management, and outcomes of Staphylococcus aureus bacteremia. Clin Infect Dis. 2008;46:1000-8.
28. Byl B, Clevenbergh P, Jacobs F, Struelens MJ, Zech F, Kentos A, Thys JP. Impact of infectious diseases specialists and microbiological data on the appropriateness of antimicrobial therapy for bacteremia. Clin Infect Dis. 1999;29:60-6.
29. Evans RS, Pestotnik SL, Classen DC, Clemmer TP, Weaver LK, Orme JF Jr, Lloyd JF, Burke JP. A computer-assisted management program for antibiotics and other antiinfective agents. N Eng J Med. 1998;338:232-8.
30. Taur Y, Smith MA. Adherence to the Infectious Diseases Society of America guidelines in the treatment of uncomplicated urinary tract infection. Clin Infect Dis. 2007;44:769-74.
31. Girotti MJ, Fodoruk S, Irvine-Meek J, Rotstein OD. Antibiotic handbook and pre-printed perioperative order forms for surgical antibiotic prophylaxis: do they work? Can J Surg. 1990;33:385-8.
32. MacDougall C, Polk RE. Antimicrobial stewardship programs in health care systems. Clin Microbiol Rev. 2005;18:638-56.
33. Mol PGM, Wieringa JE, NannanPanday PV, Gans ROB, Degener JE, Laseur M, Haaijer-Ruskamp FM. Improving compliance with hospital antibiotic guidelines: a time-series intervention analysis. J Antimicrob Chemother. 2005;55:550-7.
34. Linkin DR, Paris S, Fishman NO, Metlay JP, Lautenbach E. Inaccurate communications in telephone calls to an antimicrobial stewardship program. Infect Control Hosp Epidemiol. 2006;27: 688-94.